Titre:
  • Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
Auteur:Tosco, Lorenzo; Laenen, Annouschka; Gevaert, Thomas; Salmon, Isabelle; Decaestecker, Christine; Davicioni, Elai; Buerki, Christine; Claessens, F; Swinnen, Johan; Goffin, Karolien; Oyen, Raymond; Everaerts, Wouter; Moris, Lisa; De Meerleer, Gert; Haustermans, Karin; Joniau, Steven; P.E.A.R.L. (ProstatE cAncer Research Leuven),
Informations sur la publication:BMC cancer, 18, 1, page (354)
Statut de publication:Publié, 2018-04
Sujet CREF:Médecine pathologie humaine
Cancérologie
Histopathologie
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1471-2407
info:doi/10.1186/s12885-018-4275-z
info:pii/10.1186/s12885-018-4275-z
info:scp/85044785190
info:pmid/29606109